Product Information

DILTIAZEM 30 MG TABLET is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $0.0499 per EA under NDC 00093031805. Its NADAC has been published 665 times since Nov 28, 2013.

FDA first approved this application on May 31, 1995. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

DILTIAZEM 30 MG TABLET

Diltiazem Hydrochloride
$0.0499per EA

Strength

30 mg/1

NDC

00093031805

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

DILTIAZEM HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA074185

FDA Approved

5/31/1995

TE Code

AB

On Market Since

12/22/1995

Pharmacological Classes

Calcium Channel Antagonists
Calcium Channel Blocker
Cytochrome P450 3A4 Inhibitors

Price Statistics

The NADAC for DILTIAZEM 30 MG TABLET has been published 665 times since Nov 28, 2013, and over the history we have for it it has declined 7.2%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0499 per EA
All-time high$0.1221 (Mar 15, 2017)
All-time low$0.0495 (Jul 22, 2026)
52-week high$0.0559
52-week low$0.0495
Median price$0.0955
Average price$0.0881
Largest weekly change+56.6% (Aug 21, 2024)
Weeks tracked665
Tracking sinceNov 28, 2013

Price History

1W

+1.0%

1M

-1.8%

3M

-4.1%

6M

-4.7%

1Y

-10.7%

3Y

-38.6%

5Y

-51.6%

All

-7.2%

Generic Alternatives

The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of DILTIAZEM 30 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for DILTIAZEM 30 MG TABLET, manufactured by Teva Pharmaceuticals USA Inc., is $0.0499 per EA (NDC 00093031805), effective Aug 19, 2026.

How has the price of DILTIAZEM 30 MG TABLET changed over time?

Over the history we have for it, the NADAC for DILTIAZEM 30 MG TABLET has declined 7.2%. It has been tracked across 665 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for DILTIAZEM 30 MG TABLET?

Since Nov 28, 2013, the NADAC for DILTIAZEM 30 MG TABLET has ranged from a low of $0.0495 (Jul 22, 2026) to a high of $0.1221 (Mar 15, 2017), with a median of $0.0955 per EA.

Are there cheaper alternatives to DILTIAZEM 30 MG TABLET?

2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as DILTIAZEM 30 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures DILTIAZEM 30 MG TABLET?

DILTIAZEM 30 MG TABLET (NDC 00093031805) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.